Outcomes related to heart failure remain relatively poor, despite advances in pharmacological therapy and medical care =-=[3]-=-. Caring for CHF patients is particularly expensive because of high rates of readmissions. As the vast baby boomer population ages, all age-related illnesses will ...
If up-titration was successful in all patients, an estimated 9.8, 1.3, and 12.3 events per 100 treated patients could be prevented at 24 months by ACE inhibitor/ARB, beta-blocker, and MRA therapy, respectively. Similar numbers were 9.9, 4.7, and 13.1 if up-titration treatment decision was ...
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure Am Heart J, 138 (1999), pp. 285-290 View PDFView articleView in ScopusGoogle Scholar 15 A. Maisel B-type natriuretic peptide levels: a potential novel “white count” for congestive heart failure J Card Fai...
severe AR, and severe MR, while surgery or transcatheter therapy might affect the prognoses. However, GAI was independently related to the long-term mortality in patients without severe valvular heart disease (0.841, 0.745–0.949), after accounting for age, gender, diabetes mellitus, hypertension...
5. Are there effective therapies (medications, gene therapy, exercise, complementary and alternative therapies, orthopedic interventions, surgery) for muscular dystrophies that improve muscle strength, slow the rate of strength decline, preserve ambulation and overall function, delay time to tracheostomy ...
Several cardiovascular agents, such as diuretics and beta-blockers, can negatively affect sexual function, leading to noncompliance with therapy. Others su... MPJ Nicolai,SS Liem,S, Both,... - 《Netherlands Heart Journal Monthly Journal of the Netherlands Society of Cardiology & the Netherlands ...
therapy (CRRT) [97]. Among these patients, the most common causes of AKI were cardiovascular disease and other medical diseases, which accounted for approximately half of the patients, followed by sepsis and cardiovascular surgery; compared to all other causes, mortality was low only for ...
drug therapyprimary health carefamily practiceThere is robust evidence for effective pharmacotherapy of chronic (systolic) heart failure (CHF) which has led to the creation of guidelines, but many surveys evaluating CHF treatment show an under-utilisation of relevant drugs, while setting and patient ...
Abstract 18106: Keeping up With the Newest Guideline Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction, Resident-Driven Quality Improvement Projectdoi:10.1161/circ.148.suppl_1.18106Heart failure, adultAcute heart failureAngiotensin II Receptor Blocker (ARB)Quality improvement...
percutaneous coronary intervention was more costly than optimal medical therapy alone; hence, these findings should have discouraged routine pci in this setting. the national cardiovascular data registry (ncdr), washington, dc, and its cathpci registry (version 3.0) offers an opportunity to measure ...